Literature DB >> 19698250

[Comparison of STR-PCR and FISH value for monitoring chimerism after sex-mismatched allogeneic hematopoietic stem cell transplantation].

You-Wen Qin1, Ying Jiang, Xiao-Rui Wang, Li-Ping Wan, Shi-Ke Yan, Chun Wang.   

Abstract

This study was purposed to compare the significance of multiplex short tandem repeat polymerase chain reaction (STR-PCR) and fluorescent in situ hybridization (FISH) for monitoring chimerism after sex-mismatched allogeneic hematopoietic stem cell transplantation (allo-HSCT). The chimerism of bone marrow or peripheral blood cells from 38 patients was analyzed by STR-PCR and FISH on days 14, 28 and at 3 months after allo-HSCT. The results indicated that on day 14, the complete chimerism (CC) was detected in 14 of 30 cases by STR-PCR and in 8 of 30 cases by FISH (p > 0.05). On day 28, the CC was detected in 26 of 31 cases by STR-PCR and in 15 of 31 cases by FISH (p < 0.01). At 3 months, the CC was observed in 22 of 24 cases by STR-PCR and 17 of 24 cases by FISH (p > 0.05). 14 cases were found to have a graft rejection or relapse among 28 cases which were continuously monitored more than 3 months post the transplants. Donor cell decrease in 9 of 14 cases was proved by FISH alone. It is concluded that FISH is more sensitive than STR-PCR in early monitoring chimerism status of post-transplant and in predicting graft rejection or disease relapse.

Entities:  

Mesh:

Year:  2009        PMID: 19698250

Source DB:  PubMed          Journal:  Zhongguo Shi Yan Xue Ye Xue Za Zhi        ISSN: 1009-2137


  3 in total

1.  Early tapering of immunosuppressive agents after HLA-matched donor transplantation can improve the survival of patients with advanced acute myeloid leukemia.

Authors:  Jun Yang; Yu Cai; JieLing Jiang; LiPing Wan; HaiTao Bai; Jun Zhu; Su Li; Chun Wang; Xianmin Song
Journal:  Ann Hematol       Date:  2017-12-18       Impact factor: 3.673

2.  Low-dose anti-thymocyte globulin plus low-dose posttransplant cyclophosphamide as graft-versus-host disease prophylaxis in haploidentical peripheral blood stem cell transplantation combined with unrelated cord blood for patients with hematologic malignancies: a prospective, phase II study.

Authors:  Jun Yang; Jieling Jiang; Yu Cai; Su Li; Liping Wan; Jun Zhu; Huixia Liu; Shan Shao; Haitao Bai; Chun Wang; Xianmin Song
Journal:  Bone Marrow Transplant       Date:  2018-11-16       Impact factor: 5.483

3.  Low-dose antithymocyte globulin plus low-dose posttransplant cyclophosphamide combined with cyclosporine and mycophenolate mofetil for prevention of graft-versus-host disease after HLA-matched unrelated donor peripheral blood stem cell transplantation.

Authors:  Xi Sun; Jun Yang; Yu Cai; Liping Wan; Chongmei Huang; Huiying Qiu; Yin Tong; Xiaowei Xu; Kun Zhou; Xueying Ding; Xianmin Song
Journal:  Bone Marrow Transplant       Date:  2021-05-25       Impact factor: 5.483

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.